Roche Pharmaceuticals division revenue share by therapeutic area 2022 | Statista

This statistic shows the revenue distribution of Roche's Pharmaceuticals division from 2013 to 2022, by therapeutic area. In 2022, oncology was the leading therapeutic area of the Pharmaceuticals division generating some 44 percent of the division's total revenues. Although leading, oncology in general saw a significant decline over the last five years, losing a 20 percent share of the division's revenues.

Revenue distribution of Roche's Pharmaceuticals division from 2013 to 2022, by therapeutic area

Characteristic	Oncology	Neuroscience	Immunology	Haemophilia A	Infectious diseases	Ophthalmology	Other
2013	62%	2%	13%	-	9%	5%	9%
2014	62%	2%	14%	-	9%	5%	8%
2015	63%	2%	17%	-	5%	4%	9%
2016	64%	2%	18%	-	5%	4%	7%
2017	62.5%	3.7%	18.5%	-	3.3%	3.4%	8.6%
2018	59.6%	6.8%	18.6%	0.5%	2.5%	3.8%	8.2%
2019	56.8%	9%	17.5%	2.8%	2.2%	3.8%	7.9%
2020	52.4%	11.1%	18.5%	4.9%	1.9%	3.2%	8%
2021	45.4%	13.9%	18.6%	6.7%	4.9%	3%	7.5%
2022	43.9%	17.2%	15.8%	8.4%	4.7%	3.5%	6.5%

Loading statistic...

Download

Source

Show detailed source information?

Register for free

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2023

More information

Region

Worldwide

Survey time period

2013 to 2022

Citation formats

Other statistics on the topic
Roche

Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022

Pharmaceutical Products & Market

Top companies by COVID-19 treatment vaccines in development June 2022

Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars)

Pharmaceutical Products & Market

Total global pharmaceutical R&D spending 2014-2028

Revenue of the worldwide pharmaceutical market from 2001 to 2022 (in billion U.S. dollars)

Pharmaceutical Products & Market

Pharmaceutical market: worldwide revenue 2001-2022

Pfizer's total revenue from 2006 to 2022 (in million U.S. dollars)

Pharmaceutical Products & Market

Pfizer's total revenue 2006-2022

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Starter Account

The ideal entry-level account for individual users

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$149 USD / Month *

Professional Account

Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Roche "

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

Other statistics that may interest you Roche

Overview

5

Financials

4

Segments

5

Competitors

5

Research and development

4

Outlook

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industry

Johnson & Johnson

Cancer in the U.S.

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year

Learn more about how Statista can support your business.